Skip to main content
Equibles

Rockefeller Capital Management L.P.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1739439 NEW YORK, NY
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$614,143
-$45,282 QoQ
Shares Held
42,384
-11.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 238 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $105,853,317 across 51 Drug Manufacturers - Specialty & Generic names. RDY ranks #9 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 373,548 $62,957,776
2 ZTS
Zoetis Inc.
 330,418 $23,743,834
3 KNSA
Kiniksa Pharmaceuticals International, plc
 173,438 $11,091,360
4 HLN
Haleon plc
 122,399 $1,141,981
5 HIMS
Hims & Hers Health, Inc.
 29,716 $1,030,252
6 VTRS
Viatris Inc
 53,630 $851,642
7 UTHR
UNITED THERAPEUTICS Corp
 1,506 $815,994
8 ELAN
Elanco Animal Health Inc
 25,940 $638,382

All Filings in RDY

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $614,143 42,384
2026-03-31 $659,425 47,612
2025-12-31 $28,739 2,047
2025-09-30 $17,139 1,226
2024-03-31 $802,301 10,938
2023-12-31 $1,158,924 16,656
2022-12-31 $2,070 40
2022-09-30 $2,093 40
2022-06-30 $9,471 171
2021-12-31 $1,962 30
2021-09-30 $2,866 44
2021-06-30 $1,102 15
2021-03-31 $9,761 159
2020-09-30 $12,799 184